Taken together, these studies show that glycogen accumulation and associated transaminitis occur without inflammation or progressive liver disease in conditions with both increased ChREBP activity in GSD-1a and absent ChREBP activity in ChREBP knockout models. The gene discussed is MLXIPL; the disease is liver disorder.